FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162459074> ?p ?o ?g. }

• W2162459074 endingPage "44" @default.
• W2162459074 startingPage "39" @default.
• W2162459074 abstract "Gestational trophoblastic neoplasms (GTN) comprise a spectrum of interrelated conditions originating from the placenta. With sensitive assays for human chorionic gonadotropin (β-hCG) and current approaches to chemotherapy, most women with GTN can be cured with preservation of reproductive potential. The purpose of this analysis was to address the outcome of GTN from a developing country, as data are largely sparse from this region.We undertook a retrospective review of GTN cases treated at our centre from 2001 to 2008. Patients of GTN were assigned to low-risk (score ≤ 6) or high-risk (score ≥ 7) categories as per the modified World Health Organization scoring system. The low-risk group was treated with single-agent methotrexate (MTX) and the high-risk group received the EMA/CO regimen. Salvage therapies were EMA/EP or BEP. Treatment was continued until serum β-hCG values were normal for three consecutive chemotherapy cycles, after which the patients were kept on follow-up.In total, 70 GTN patients were treated at our institution during this period; 48 (68%) were low-risk and 22 (32%) were in the high-risk category. The median β-hCG level was 50 000 IU/l. The lung was the most common site of metastasis, seen in 15 (21%) patients. Among 48 low-risk patients, 37 (77%) received chemotherapy, of whom 25 (68%) were treated with MTX and 24 (96%) achieved a complete response. Twelve low-risk patients (32%) received EMA/CO therapy; 10 (83%) achieved a complete response. The 22 high-risk patients received EMA/CO and of these 16 (73%) achieved a complete response, two (9%) progressed, two (9%) died of progressive disease and two (9%) were lost to follow-up. Grade 3/4 toxicities with MTX included mucositis in two (8%) and neutropenia in five (21%) patients. At a median follow-up of 16.6 months, overall survival in the low- and high-risk groups was 100 and 88.8%, respectively.Risk-stratified treatment of GTN was associated with acceptable toxicity and resulted in outcome that was comparable with international standards." @default.
• W2162459074 created "2016-06-24" @default.
• W2162459074 creator A5000668160 @default.
• W2162459074 creator A5015784548 @default.
• W2162459074 creator A5026906912 @default.
• W2162459074 creator A5029054221 @default.
• W2162459074 creator A5044217179 @default.
• W2162459074 creator A5055543487 @default.
• W2162459074 creator A5076171969 @default.
• W2162459074 creator A5077780198 @default.
• W2162459074 creator A5091717418 @default.
• W2162459074 date "2014-01-01" @default.
• W2162459074 modified "2023-10-09" @default.
• W2162459074 title "Outcome of Gestational Trophoblastic Neoplasia: Experience from a Tertiary Cancer Centre in India" @default.
• W2162459074 cites W1929177538 @default.
• W2162459074 cites W1955563698 @default.
• W2162459074 cites W1965431206 @default.
• W2162459074 cites W1996258414 @default.
• W2162459074 cites W2007736080 @default.
• W2162459074 cites W2010443570 @default.
• W2162459074 cites W2023273774 @default.
• W2162459074 cites W2023952758 @default.
• W2162459074 cites W2037865730 @default.
• W2162459074 cites W2055635516 @default.
• W2162459074 cites W2093815392 @default.
• W2162459074 cites W2106572315 @default.
• W2162459074 cites W2148665128 @default.
• W2162459074 cites W2160168356 @default.
• W2162459074 cites W2162198154 @default.
• W2162459074 doi "https://doi.org/10.1016/j.clon.2013.08.010" @default.
• W2162459074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24051171" @default.
• W2162459074 hasPublicationYear "2014" @default.
• W2162459074 type Work @default.
• W2162459074 sameAs 2162459074 @default.
• W2162459074 citedByCount "16" @default.
• W2162459074 countsByYear W21624590742014 @default.
• W2162459074 countsByYear W21624590742015 @default.
• W2162459074 countsByYear W21624590742016 @default.
• W2162459074 countsByYear W21624590742017 @default.
• W2162459074 countsByYear W21624590742018 @default.
• W2162459074 countsByYear W21624590742020 @default.
• W2162459074 countsByYear W21624590742021 @default.
• W2162459074 countsByYear W21624590742023 @default.
• W2162459074 crossrefType "journal-article" @default.
• W2162459074 hasAuthorship W2162459074A5000668160 @default.
• W2162459074 hasAuthorship W2162459074A5015784548 @default.
• W2162459074 hasAuthorship W2162459074A5026906912 @default.
• W2162459074 hasAuthorship W2162459074A5029054221 @default.
• W2162459074 hasAuthorship W2162459074A5044217179 @default.
• W2162459074 hasAuthorship W2162459074A5055543487 @default.
• W2162459074 hasAuthorship W2162459074A5076171969 @default.
• W2162459074 hasAuthorship W2162459074A5077780198 @default.
• W2162459074 hasAuthorship W2162459074A5091717418 @default.
• W2162459074 hasConcept C126322002 @default.
• W2162459074 hasConcept C131872663 @default.
• W2162459074 hasConcept C141071460 @default.
• W2162459074 hasConcept C143998085 @default.
• W2162459074 hasConcept C167135981 @default.
• W2162459074 hasConcept C2775948956 @default.
• W2162459074 hasConcept C2776256026 @default.
• W2162459074 hasConcept C2776694085 @default.
• W2162459074 hasConcept C2778336483 @default.
• W2162459074 hasConcept C2779234561 @default.
• W2162459074 hasConcept C2780832733 @default.
• W2162459074 hasConcept C2781059491 @default.
• W2162459074 hasConcept C2781413609 @default.
• W2162459074 hasConcept C2909593222 @default.
• W2162459074 hasConcept C29456083 @default.
• W2162459074 hasConcept C54355233 @default.
• W2162459074 hasConcept C71315377 @default.
• W2162459074 hasConcept C71924100 @default.
• W2162459074 hasConcept C86803240 @default.
• W2162459074 hasConceptScore W2162459074C126322002 @default.
• W2162459074 hasConceptScore W2162459074C131872663 @default.
• W2162459074 hasConceptScore W2162459074C141071460 @default.
• W2162459074 hasConceptScore W2162459074C143998085 @default.
• W2162459074 hasConceptScore W2162459074C167135981 @default.
• W2162459074 hasConceptScore W2162459074C2775948956 @default.
• W2162459074 hasConceptScore W2162459074C2776256026 @default.
• W2162459074 hasConceptScore W2162459074C2776694085 @default.
• W2162459074 hasConceptScore W2162459074C2778336483 @default.
• W2162459074 hasConceptScore W2162459074C2779234561 @default.
• W2162459074 hasConceptScore W2162459074C2780832733 @default.
• W2162459074 hasConceptScore W2162459074C2781059491 @default.
• W2162459074 hasConceptScore W2162459074C2781413609 @default.
• W2162459074 hasConceptScore W2162459074C2909593222 @default.
• W2162459074 hasConceptScore W2162459074C29456083 @default.
• W2162459074 hasConceptScore W2162459074C54355233 @default.
• W2162459074 hasConceptScore W2162459074C71315377 @default.
• W2162459074 hasConceptScore W2162459074C71924100 @default.
• W2162459074 hasConceptScore W2162459074C86803240 @default.
• W2162459074 hasIssue "1" @default.
• W2162459074 hasLocation W21624590741 @default.
• W2162459074 hasLocation W21624590742 @default.
• W2162459074 hasOpenAccess W2162459074 @default.
• W2162459074 hasPrimaryLocation W21624590741 @default.
• W2162459074 hasRelatedWork W1571579786 @default.
• W2162459074 hasRelatedWork W2035770108 @default.

• next